omega-n-methylarginine has been researched along with pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid in 1 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid) | Trials (pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid) | Recent Studies (post-2010) (pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 598 | 0 | 83 |
| Protein | Taxonomy | omega-n-methylarginine (IC50) | pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid (IC50) |
|---|---|---|---|
| P2X purinoceptor 1 | Rattus norvegicus (Norway rat) | 0.5495 | |
| P2X purinoceptor 2 | Rattus norvegicus (Norway rat) | 1.6 | |
| P2X purinoceptor 3 | Rattus norvegicus (Norway rat) | 0.24 | |
| P2X purinoceptor 1 | Mus musculus (house mouse) | 0.099 | |
| P2X purinoceptor 4 | Rattus norvegicus (Norway rat) | 2.6 | |
| P2X purinoceptor 6 | Rattus norvegicus (Norway rat) | 2 | |
| P2X purinoceptor 3 | Homo sapiens (human) | 0.24 | |
| P2X purinoceptor 5 | Homo sapiens (human) | 8.45 | |
| P2X purinoceptor 4 | Homo sapiens (human) | 6.1 | |
| P2X purinoceptor 7 | Homo sapiens (human) | 1.18 | |
| P2X purinoceptor 2 | Homo sapiens (human) | 2.02 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dacey, RG; Dietrich, HH; Hongo, K; Horiuchi, T | 1 |
1 other study(ies) available for omega-n-methylarginine and pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid
| Article | Year |
|---|---|
Comparison of P2 receptor subtypes producing dilation in rat intracerebral arterioles.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Arterioles; Brain; Cerebrovascular Circulation; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hydrogen-Ion Concentration; In Vitro Techniques; Indomethacin; Male; Microscopy, Video; Nitric Oxide; omega-N-Methylarginine; Potassium Chloride; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y2; Thionucleotides; Vascular Patency; Vasodilation | 2003 |